Edgewise Therapeutics, Inc. (EWTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$39.58
+1.05%
Mkt Cap $4.23B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 7, 2026 | — | — | — | -$0.50 | -$0.46 | +8.00% |
| Q1 2026 Feb 26, 2026 | — | — | — | -$0.43 | -$0.47 | -9.30% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.40 | -$0.39 | +2.50% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.42 | -$0.34 | +19.05% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.45 | -$0.43 | +4.44% |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.39 | -$0.42 | -7.69% |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.37 | -$0.36 | +2.70% |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.36 | -$0.34 | +5.56% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.39 | -$0.33 | +15.38% |
| Q1 2024 Feb 22, 2024 | — | $2.25M | — | -$0.44 | -$0.47 | -6.82% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.40 | -$0.41 | -2.50% |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.41 | -$0.34 | +17.07% |
| Q2 2023 May 11, 2023 | — | — | — | -$0.37 | -$0.36 | +2.70% |
| Q1 2023 Feb 23, 2023 | — | — | — | -$0.36 | -$0.31 | +13.89% |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.36 | -$0.34 | +5.56% |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.34 | -$0.32 | +5.88% |
| Q2 2022 May 11, 2022 | — | — | — | -$0.29 | -$0.30 | -3.45% |
| Q1 2022 Feb 24, 2022 | — | — | — | -$0.28 | -$0.26 | +7.14% |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.22 | -$0.26 | -18.18% |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.18 | -$0.21 | -16.67% |
| Q2 2021 May 13, 2021 | — | — | — | -$0.16 | -$4.37 | -2631.25% |
| Q1 2021 Mar 26, 2021 | — | — | — | — | -$0.18 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.31 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.19 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.16 | — |